Cephalosporin Market Analysis | 2023-2028

Market Insights

The cephalosporin market was estimated at USD 14.67 billion in 2022 and is likely to grow at a CAGR of 2.8% during 2023-2028 to reach USD 17.37 billion in 2028.

Want to know more about the market scope? Register Here

Market Dynamics

Introduction

Cephalosporin is a bactericidal and β-lactam antibiotic mainly derived from the fungus Acremonium that is used to treat bactericidal infections such as skin infections, pneumonia, tonsillitis, strep throat, gonorrhea, staph infections, and bronchitis among others. It inhibits enzymes in the cell wall of the susceptible bacteria and disrupts cell synthesis. Cephalosporin is majorly designated for prophylaxis as well as for the treatment of infections caused by bacteria.

COVID-19 Impact

The outbreak of the COVID-19 virus has considerably affected the cephalosporin industry. Cephalosporin has not been proven highly effective against viruses. β-lactam antibiotics such as cephalosporin possess a bacteriostatic effect. The bacteriostatic action results in the action of subduing the growth of bacteria. β-lactam antibiotics act by preventing peptidoglycan synthase, which is an enzyme necessary for the growth of bacterial cell walls. However, cephalosporin can help to obstruct SARS-CoV-2 but has a minor impact on the market growth.

Market Drivers

The growing prevalence of infectious diseases and the increase in funding for the development of antibiotics are some of the key factors bolstering the product demand. Additionally, the surge in R&D activities for the production of combination drugs and the rising demand for antibacterials further augment the market growth. Moreover, the discovery of innovative prospect molecules and the introduction of novel combination therapies to treat antibiotic-resistant infections are likely to provide lucrative opportunities to industry participants. However, the side effects of cephalosporin are likely to hinder the industry's expansion.

Want to have a closer look at this market report? Click Here

Key Players

Key players operating in the global market are:

• Aristo Pharmaceuticals Ltd (India),
• Baxter International (The U.S.),
• F. Hoffmann-La Roche AG (Switzerland),
• GlaxoSmithKline PLC (UK),
• Lupin Pharmaceuticals Inc. (India),
• Macleods Pharmaceuticals Ltd (India),
• Mankind Pharma (India),
• Merck & Co. Inc. (The U.S.),
• Pfizer Inc. (The U.S.), and
• Teva Pharmaceutical Industries Ltd. (Israel).

Note: The above list does not necessarily include all the top players in the market.

Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com

Segment Analysis

By Type

By type, the cephalosporin market has been segmented into branded and generic.

• Under these, the generic segment held a considerable market share in 2022 and is likely to register the fastest CAGR during the review period.
• This is mainly attributed to the easy availability of drugs at a lower cost when compared to branded drugs.
• Also, the pharmacological effects of generic drugs are almost the same as those of their brand-name equivalents.

Regional Insights

By region, the Asia Pacific market witnessed the highest market share in 2022 and is estimated to grow at a substantial CAGR during the assessment period.

• This is mainly ascribed to the rise in consumption of cephalosporin, the upsurge in demand for over-the-counter drugs, easier availability, and increasing bacterial infections in the Asia Pacific.
• Moreover, growing healthcare expenditure and improving standards of living with large population growth further boost regional growth.

Know the high-growth countries in this report. Register Here

Research Methodology

• This strategic assessment report from Stratview Research provides a comprehensive analysis that reflects cephalosporin market realities and future market possibilities for the forecast period.
• The report segments and analyzes the market in the most detailed manner in order to provide a panoramic view of the market.
• The vital data/information provided in the report can play a crucial role for market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate growth strategies to expedite their growth process.
• This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.
• More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data.
• We conducted more than 15 detailed primary interviews with market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into market dynamics and will enable strategic decision-making for existing market players as well as those willing to enter the market. The following are the key features of the report:

• Market structure: Overview, industry life cycle analysis, supply chain analysis.
• Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis.
• Market trend and forecast analysis.
• Market segment trend and forecast.
• Competitive landscape and dynamics: Market share, Service portfolio, New Product Launches, etc.
• COVID-19 impact and its recovery curve
• Attractive market segments and associated growth opportunities.
• Emerging trends.
• Strategic growth opportunities for the existing and new players.
• Key success factors.

Market Segmentation

This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

The cephalosporin market is segmented into the following categories.

By Type

• Branded
• Generic

By Generation Type

• First-Generation
• Second-Generation
• Third-Generation
• Fourth-Generation
• Fifth-Generation

By End Use Type

• Respiratory Tract Infection
• Skin Infection
• Ear Infection
• Sexually Transmitted Infection
• Urinary Tract Infection
• Others

By Route of Administration Type

• Intravenous
• Oral

By Region

• North America (Country Analysis: The USA, Canada, and Mexico)
• Europe (Country Analysis: Germany, France, The UK, Russia, and the Rest of Europe)
• Asia-Pacific (Country Analysis: China, India, Australia, South Korea, and the Rest of Asia-Pacific)
• Rest of the World (Country Analysis: Saudi Arabia, Brazil, and Others)

Click Here, to learn the market segmentation details.

Report Customization Options

Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to three players)
• SWOT analysis of key players (up to three players)

Competitive Benchmarking

• Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.